| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.07 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |